Silymarin: An effective hepatoprotective agent against diethylnitrosamine- induced hepatotoxicity in rats

Pharmaceutical Biology

Volumn 45, Issue 9, 2007, Pages 707-714

  Pradeep, Kannampalli ^a   Mohan, Chandrasekaran Victor Raj ^a   Gobianand, Kuppannan ^a   Karthikeyan, Sivanesan ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Diethylnitrosamine; Hepatotoxicity; Lipid peroxidation; Silymarin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA TOCOPHEROL; ASCORBIC ACID; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CATALASE; DIETHYLNITROSAMINE; GAMMA GLUTAMYLTRANSFERASE; LACTATE DEHYDROGENASE; SILYMARIN; SUPEROXIDE DISMUTASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; LACTATE DEHYDROGENASE BLOOD LEVEL; LIPID PEROXIDATION; LIVER; LIVER PROTECTION; LIVER TOXICITY; MALE; NONHUMAN; OXIDATIVE STRESS; QUANTITATIVE ANALYSIS; RAT;

RATTUS; RATTUS NORVEGICUS;

EID: 36248991330     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.1080/13880200701575254     Document Type: Article

References (43)

1. Ahmed S, Rahman A, Mathur M, Athar M, Sultana S (2001): Antitumour promoting activity of Asteracantha longifolia against experimental hepatocarcinogenesis in rats. Food Chem Toxicol l39: 19-28.
2. Akintonwa DA (1985): The derivation of nitrosamines from some therapeutic amines in the human environment. Ecotocicol Environ Saf 9: 64-70.
3. Barbisan LF, Scolastici C, Miyamoto M, Salvadori DMF, Ribeiro LR, daEira AF, deCamargo JLV (2003): Effects of crude extracts of Agaricus blazei on DNA damage and on rat liver carcinogenesis induced by diethylnitrosamine. Gen Mol Res 2: 295-308.
4. Batakov EA (2001): Effect of Silybum marianum oil and legalon on lipid peroxidation and liver antioxidant systems in rats intoxicated with carbon tetrachloride. Eksp Klin Farmakol 64: 53-55.
5. Belmenthal M (1998): The Complete German Commission E Monograph: Therapeutic Guide to Herbal Medicine. Austin, American Botanical Council, and Boston, Integrative Medicine Communications, p. 163.
6. Beuttner GR (1993): The peeking order of free radicals and antioxidants: Lipid peroxidation, alpha-tocopherol and ascorbate. Arch Biochem Biophys 300: 535-543.
7. Bhattacharjee R, Sil PC (2006): The protein fraction of Phyllanthus niruri plays a protective role against acetaminophen induced hepatic disorder via its antioxidant properties. Phytother Res 20: 595-601.
8. Choksi S, Patel SS, Saluja AK (2000): Silymarin - a promising herbal hepatoprotective drug. Ind Drugs 37: 566-569.
9. Das S (1994): Vitamin E in the genesis and prevention of cancer. A review. Acta Oncol 33: 615-619.
10. El-Samaligy MS, Afifi NN, Mahmoud EA (2006): Evaluation of hybrid liposomes-encapsulated silymarin regarding physical stability and in vivo performance. Int J Pharmacy 319: 121-129.
11. Feher J, Deak G, Muzes G, Lang I, Niederland V, Nekam K (1989): Liver protection action of silymarin therapy in chronic alcoholic liver diseases. Orv Hetil 130: 2723-2727.
12. Flora K, Hahn M, Rosen H, Benner K (1998): Milk thistle (Silybum marianum) for the therapy of liver diseases. Am J Gastroenterol 93: 139-143.
13. Fraschini F, Demartini G, Esposti D (2002): Pharmacology of silymarin. Clin Drug Invest 22: 51-65.
14. Fridovich I (1986): Superoxide dismutases. Adv Enzymol 58: 61-97.
15. Goldsworthy TL, Hanigan MH (1986): Models of hepatocarcinogenesis in the rat - contrast and comparisons. CRC Crit Rev Toxicol 17: 61-89.
16. Gonzalez-Correa JA, de la Cruz JP, Gordillo J, Urena I, Redondo L, Sanchez de la Cuesta F (2002): Effects of silymarin MZ-80 on hepatic oxidative stress in rats with biliary obstruction. Pharmacology 64: 18-27.
17. Huseby NE, Ingebretsen OC (1993): The level of γ- glutamyltransferase in serum, effect of carbohydrate heterogeneity on clearance rate. Scand J Clin Lab Invest Suppl 215: 93-100.
18. IARC (1972): Monograph on the Evaluation of Carcinogenic Risk of Chemicals to Man, Vol. 1. Lyon, International Agency for Research on Cancer, pp. 107-124.
19. Jose JK, Kuttan R, Bhattacharaya RK (1998): Effect of Emblica officinalis extract on hepatocarcinogenesis and carcinogen metabolism. J Clin Biochem Nutr 25: 31-39.
20. King J (1965a): The phosphohydrolases - acid and alkaline phosphatases. In: Practical Clinical Enzymology. London, D. Van Nostrand Co Ltd., pp. 191-208.
21. King J (1965b): The dehydrogenase (or) oxidoreductase - Lactate dehydrogenase. In: Practical Clinical Enzymology. London, D. Van Nostrand Co Ltd., pp. 83-93.
22. Kren V, Walterova D (2005): Silybin and silymarin - new effects and applications. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 149: 29-41.
23. Liao DJ, Blanck A, Eneroth P, Gustafsson JA, Hallstrom IP (2001): Diethylnitrosamine causes pituitary damage, disturbs hormone levels and reduces sexual dimorphism of certain liver functions in the rat. Environ Health Perspect 109: 943-947.
24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951): Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
25. Malloy HT, Evelyn KA (1937): The determination of bilirubin with photoelectric colorimeter. J Biol Chem 119: 481-490.
26. Marklund S, Marklund G (1974): Involvement of the superoxide anion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47: 469-474.
27. Muriel P, Garciapina T, Perez-Alvarez V, Mourelle M (1992): Silymarin protects against paracetamol induced lipid peroxidation and liver damage. J Appl Toxicol 12: 439-442.
28. 4 liver damage. J Appl Toxicol 10: 275-279.
29. Ohkawa H, Ohishi N, Yagi K (1979): Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351-358.
30. Omaye ST, Turnbull JD, Sauberlich HE (1979): Selected methods for the determination of ascorbic acid in animal cells, tissues and fluids. Methods Enzymol 62: 1-11.
31. Percy ME (1984): Catalase: An old enzyme with a new role? Can J Biochem Cell Biol 62: 1006-1014.
32. Pitot H, Campbell H, Maronpot R, Bawa N, Rizvi T, Xu YH, Sargent L, Dragan Y, Pyron M (1989): Critical parameters in the quantitation of the stages of initiation, promotion and progression in one model of hepatocarcinogenesis in the rat. Toxicol Pathol 17: 594-612.
33. Rosalki SB, Rau D (1972): Serum γ-glutamyl transpeptidase activity in alcoholism. Clin Chim Acta 39: 41-47.
34. Saller R, Meier R, Brignoli R (2001): The use of silymarin in the treatment of liver diseases. Drugs 61: 2035-2063.
35. Sallie R, Tredger JM, Willam R (1991): Drugs and the liver. Biopharm Drug Dispos 12: 251-259.
36. Sinha AK (1972): Colorimetric assay of catalase. Anal Biochem 47: 389-394.
37. Varley H, Gowenlock AH, Bell M (1976): In: Practical Clinical Biochemistry, Vol. II, Hormones, Vitamins, Drugs and Poisons, 5th ed. London, William Heinemann Medical Books Ltd, pp. 222-223.
38. Vasudevan DM, Sreekumari S (2001): In: Text Book of Biochemistry for Medical Students, 3rd ed. New Delhi, Jaypee Brothers Medical Publishers (P) Ltd, p. 271.
39. Viani P, Cervato G, Fiorilli A, Cestaro B (1991): Age-related differences in synaptosomal peroxidative damage and membrane properties. J Neurochem 56: 253-258.
40. Vitaglione P, Morisco F, Caporaso N, Fogliano V (2004): Dietary antioxidant compounds and liver health. Crit Rev Food Sci Nutr 44: 575-586.
41. Wooten IDP (1964): In: Microanalysis in Medical Biochemistry. London, J & A Churchill Ltd, pp. 101-103.
42. Yoshikawa M, Murakami T, Kishi A, Kageura T, Matsuda H (2001): Medicinal flowers III. Marigold (I): Hypoglycaemic, gastric emptying inhibitory and gastro protective principles and new oleane type triterpene oligoglycosides, calendasaponins A, B, C and D from Egyptian Calendula officinalis. Chem Pharm Bull 49: 863-870.
43. Zielinska-Przyjemska M, Wiktorowicz K (2006): An in vitro study of the protective effect of the flavonoid silydianin against reactive oxygen species. Phytother Res 20: 115-119.